Caturano, A.; D’Ardes, D.; Simeone, P.G.; Lessiani, G.; Gregorio, N.D.; Andreetto, L.; Grassi, D.; Serra, C.; Santilli, F.; Guagnano, M.T.;
et al. SGLT2 Inhibitors and GLP-1 Receptor Agonists in PAD: A State-of-the-Art Review. J. Clin. Med. 2025, 14, 5549.
https://doi.org/10.3390/jcm14155549
AMA Style
Caturano A, D’Ardes D, Simeone PG, Lessiani G, Gregorio ND, Andreetto L, Grassi D, Serra C, Santilli F, Guagnano MT,
et al. SGLT2 Inhibitors and GLP-1 Receptor Agonists in PAD: A State-of-the-Art Review. Journal of Clinical Medicine. 2025; 14(15):5549.
https://doi.org/10.3390/jcm14155549
Chicago/Turabian Style
Caturano, Alfredo, Damiano D’Ardes, Paola Giustina Simeone, Gianfranco Lessiani, Nicoletta Di Gregorio, Lorenzo Andreetto, Davide Grassi, Carla Serra, Francesca Santilli, Maria Teresa Guagnano,
and et al. 2025. "SGLT2 Inhibitors and GLP-1 Receptor Agonists in PAD: A State-of-the-Art Review" Journal of Clinical Medicine 14, no. 15: 5549.
https://doi.org/10.3390/jcm14155549
APA Style
Caturano, A., D’Ardes, D., Simeone, P. G., Lessiani, G., Gregorio, N. D., Andreetto, L., Grassi, D., Serra, C., Santilli, F., Guagnano, M. T., Piscaglia, F., Ferri, C., Cipollone, F., & Boccatonda, A.
(2025). SGLT2 Inhibitors and GLP-1 Receptor Agonists in PAD: A State-of-the-Art Review. Journal of Clinical Medicine, 14(15), 5549.
https://doi.org/10.3390/jcm14155549
